posted on 2019-12-05, 01:13authored byChristophe Hardouin, Sandrine Baillard, François Barière, Chloé Copin, Anthony Craquelin, Solenn Janvier, Sylvain Lemaitre, Stéphane Le Roux, Olivier Russo, Sébastien Samson
Our efforts toward the process development of drug candidate 1 are described in a series of two papers. This manuscript
focuses on the synthesis of kilogram quantities of acid precursor 2 to provide batches of material for preclinical studies and
first-in-human clinical trials. Our approach relies on a chiral resolution
to furnish the desired stereocenter, a cryogenic carboxylation, and N-alkylation of chloride derivative 26 prepared
by a Suzuki coupling. Further efforts pursued to improve those key
steps that could become issues on larger scale are also discussed.